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1  | INTRODUC TION
Vitamin D is required for normal development and bone health. 
Vitamin D deficiency is known to cause rickets in children and osteo‐
malacia in adults. Furthermore, recent studies indicate that vitamin 
D status is implicated in the development of diabetes mellitus1 and 
other chronic conditions.2 Vitamin D deficiency has been reported 
to be common in many countries.3,4 These findings have led to an 
increase in vitamin testing worldwide, which has placed considerable 
demands on clinical laboratories.
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Abstract
Background: There	is	an	increasing	demand	for	serum	25‐OH	VitD	testing	globally,	
and this has led to the greater use of automated immunoassays. These may be more 
prone to non‐specific interference, that is thought to be related to pre‐analytical sta‐
bility	of	biological	samples.	We	have	investigated	the	changes	in	serum	25‐OH	VitD	
concentrations that are caused by storage and mixing conditions, and if such changes 
are statistical, or clinically important.
Methods: Blood samples were collected into plain tubes from 31 healthy donors. 
After	separation,	serum	samples	were	stored	at	−20°C	and	analysis	was	carried	out	
with	and	without	mixing	(vortexing)	at	different	time	intervals	of	days	(0,	1,	2,	3,	4,	
5,	15,	and	30).	All	samples	were	analyzed	using	a	chemiluminescent	immunoassay.
Results: Mean	 serum	25‐OH	VitD	 concentrations	 for	 subsequent	 days	 of	 storage	
compared with day 0 showed a significant time effect (P	<	.05)	except	for	the	sam‐
ples on day 1 (P	=	.654)	in	non‐vortexed	samples	and	day	2	(P	=	.087),	5	(P	=	.118)	and	
30 (P	=	.118)	in	vortexed	samples.	Comparing	values	for	vortexed	and	non‐vortexed	
samples	on	the	same	day,	serum	25‐OH	VitD	showed	a	significant	difference	on	days	
1 (P	=	 .003),	4	 (P	=	 .037),	5	 (P	=	 .002),	 and	30	 (P	=	 .025).	However,	 the	maximum	
change	value	was	8.85%	which	was	less	than	the	known	total	allowable	error	(TEa)	
and	reference	change	value	(RCV)	for	serum	25‐OH	VitD.
Conclusion: 25‐OH	VitD	is	pre‐analytically	stable	after	long‐term	sample	storage	at	
−20°C	and	can	be	analyzed	without	vortexing.	This	may	be	beneficial	 for	both	re‐
search and diagnostic laboratories.
K E Y W O R D S
effect, mixing, pre‐analytical, stability, storage, vitamin D
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It is possible that pre‐analytical factors may affect the reli‐
ability	of	serum	25‐hydroxy	vitamin	D	(25‐OH	VitD)	estimations,	
and this is important if appropriate clinical interventions are to be 
made.	Hence,	 it	 is	 important	 to	know	how	pre‐analytical	 factors	
may affect the results of testing. These factors include sample sta‐
bility on storage and processing of samples after defrosting. This 
would be particularly important when analysis is not carried out 
on	a	daily	basis,	and	samples	are	frozen	for	various	lengths	of	time	
before	estimation.	However,	 to	date,	 there	are	 limited	published	
data	 on	 pre‐analytical	 stability	 of	 25‐OH	 VitD	 in	 human	 blood	
following storage at various temperatures, and for various peri‐
ods.	One	 study	 focused	 on	 the	 effects	 of	 repeated	 freeze‐thaw	
cycles.5	Another	study	investigated	the	stability	of	serum	25‐OH	
VitD levels over time under various sample storage conditions 
using specimens from only eight patients.6	A	recent	study	exam‐
ined	the	effect	of	storage	at	−20°C	in	the	primary	collection	tube	
on	25‐OH	VitD	measured	by	immunoassay.7 These three studies 
and	other	studies	(Table	1)	have	reported	vitamin	D	to	be	a	stable	
analyte on storage with no concern about using the quality re‐
quirement parameters to estimate the clinical decision thresholds. 
However,	these	studies	have	been	limited	either	by	the	small	num‐
bers of specimens examined or by the chosen time intervals for 
storage. Furthermore, no previous study has examined the effects 
of	whether	samples	were	mixed	following	thawing	on	25‐OH	VitD	
stability. Vortex mixing is usually used to ensure homogenity of 
sample	following	thawing	of	frozen	samples,	adding	an	additional	
step to the analytical process.
Therefore, the aim of the present study was to assess the stabil‐
ity	of	25‐OH	VitD	over	a	longer	period	of	time	and	to	investigate	the	
effect	of	vortex	mixing	on	the	results	of	serum	25‐OH	VitD	analysis.	
In addition to this, our study aimed to investigate whether the po‐
tential changes in the results are clinically significant or not, as this 
has not been discussed in the previous studies.
2  | METHODOLOGY
2.1 | Subjects identification
Subjects were recruited randomly for the study from healthy blood 
donors	at	King	Abdulaziz	Medical	City,	Western	Region	(National	
Guard	Health	Affairs	(NGHA))	without	regards	to	vitamin	D	intake.	
The	study	was	approved	by	the	Institutional	Review	Board	(IRB)	at	
King	 Abdullah	 International	Medical	 Research	 Center	 (KAIMRC)	
for	ethical	considerations	(SP18/427/J).	All	participants	signed	an	
TA B L E  1  Summary	of	previous	studies	about	25‐OH	VitD	stability
Publication
No. of 
samples
Storage 
Temp. Analyzer
Type of 
Investigation Tube type Period Outcome
Wielders et 
al, 20096
8 ‐20°C,
Dark	6°C
Dark RT
Bench RT
Cobas	E601	
(Roche)
Temperature and 
freeze‐thawing	
cycles
Plain	(serum) Up	to	
2 mo
Frozen	and	unfrozen	serum	samples	
are	reliable	for	analysis	up	to	3	d.	No	
effect	of	light	exposure	or	freeze‐
thawing	cycles	on	25‐OH	VitD	levels.
Antoniucci,	
D.	M	et	al,	
2005.88
20 ‐70°C
RT
RIA	(DiaSorin) Freeze‐thawing	
cycles
Plain	(serum) 3 d After	thawing	and	refreezing	up	to	
four	times	25‐OH	VitD	results	are	
still reliable.
Hayden	Y	et	
al, 20157
19 ‐20°C Cobas	E602 Storage, tem‐
perature, and 
sample type
SST	(serum) 144 d 25‐OH	VitD	can	be	stored	in	the	
primary	SST	at	–20°C	without	statis‐
tically significant change.
Bozkurt	et.,	
201813
153 RT
2‐8°C
‐20°C
‐40°C
IDS‐ISYS Temperature and 
storage time
SST	(serum) 3 mo There was no significant statistical 
difference	in	25‐OH	VitD	level	when	
they compared with first day sample 
level.
Chu‐Ling	Yu	
201014
20 RT,
2‐8°C
Liaison	(DiaSorin)	
and	RIA
Delay in separa‐
tion, sample 
type, and stor‐
age time
Plain	(serum),	
EDTA	
(plasma),	
Heparin	
(plasma)
NA No	need	for	immediate	analysis	of	
blood samples after collection or for 
the	choice	of	a	tube	type.	The	25‐OH	
VitD	in	heparinized	plasma	may	be	
higher	than	in	serum	or	EDTA	plasma
Ayfer	Colak	
et al, 
201315
15 RT
2‐8°C
‐20°C
‐80°C
Cobas	E	411 Storage condi‐
tions and 
sample type
SST	(serum)	
and	EDTA	
(plasma)
3 mo There is no statistically significant dif‐
ference between serum and plasma 
25‐OH	VitD	at	different	storage	
conditions.
Borai	A.,	
20168
50 −80°C HPLC,	Architect	
(Abbott),	and	
Liaison	(Diasorin)
Sample type SST	(serum)	
and Plain 
(serum)
6 mo The gel in SST does not interfere with 
the	measurement	of	25‐OH	Vit	D.
Note: Immunoassay	principles:	Cobas,	electrochemiluminescence;	RIA,	radioimmunoassay;	IDS‐ISYS;	chemiluminescent;	Architect,	chemilumines‐
cent;	Liaison,	chemiluminescent.
Abbreviations:	RT,	room	temperature;	SST,	serum	separator	tube,	HPLC,	high	pressure	liquid	chromatography.
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informed consent form after explaining the purpose of the study, 
and being assured that it imposed no additional risk. Blood sam‐
ples were drawn in the phlebotomy area of the laboratory depart‐
ment,	 King	 Saud	 Bin	 Abdulaziz	 University	 for	 Health	 Sciences	
(KSAU‐HS).
2.2 | Specimens collection
All	specimens	were	obtained	on	a	single	day.	Blood	was	collected	
from	each	subject	into	two	plain	(red	top)	tubes	(Becton‐Dickinson)	
using standard venesection technique. Samples with insufficient 
volume	 (<8	 mL	 of	 blood),	 lipemia,	 or	 hemolysis	 were	 excluded	
from the study. Specimens were centrifuged within 1 hour of 
collection,	 and	 the	 serum	 separated	 and	 aliquoted	 into	 1.0	 mL	
Eppendorf	 tube	with	 500	µL	 of	 serum.	Aliquots	were	 stored	 at	
−20°C	except	for	two	per	subject	that	were	analyzed	on	the	day	
of	 collection	 (day	 0).	One	 aliquot	was	 vortexed	 for	 10	 seconds,	
and	the	second	analyzed	without	vortexing.	This	procedure	was	
repeated using the stored aliquots on days 1, 2, 3, 4, 5, and 30. 
All	specimens	were	measured	for	total	25‐OH	VitD	concentration	
using	 a	 chemiluminescent	 immunoassay	 (CLIA)	 on	 an	 Architect	
i2000	analyzer.	The	method	is	a	direct	competitive	assay	(Ag‐Ab	
reaction),	which	detects	both	active	 forms	of	vitamin	D	 (25‐OH	
VitD2	and	25‐OH	VitD3).
The	 assay	 is	 standardized	 immunoassay	 and	 traceable	 to	 na‐
tional	institute	of	standards	and	technology	(NIST).	The	coefficient	
of	variation	(CV)	values	for	 intra‐assay	(1.4%‐3.7%)	and	inter‐assay	
(2.7%‐4.6%)	were	published	in	our	previous	study.8 The laboratory at 
King	Abdulaziz	Medical	City	is	accredited	by	the	College	of	American	
Pathologists. It participates in a rigorous program of internal quality 
control	and	external	quality	assessment.	All	internal	quality	control	
results and calibration were within the acceptable limits in each indi‐
vidual day of research samples analysis.
2.3 | Statistical analysis
Statistical analysis was done using SPSS software version 22. 
Comparison between group means was performed using paired t tests 
and	across	different	groups	using	analysis	of	variance	(ANOVA).	A	two‐
tailed t test was conducted using an α level of .05 for all statistical tests.
3  | RESULTS
The study comprised 31 subjects, with a mean age ± SD of 
35	±	15	years	and	20	of	whom	were	males	 (64.5%).	Mean	weight	
and height ± SD reported were 65 ± 16 kg and 1.62 ± 0.09 m, re‐
spectively. Four subjects were taking vitamin D supplements. The 
mean	serum	25‐OH	VitD	estimated	values	on	different	days,	with	
and without vortexing are shown in Table 2. The minimum and maxi‐
mum	25‐OH	VitD	levels	of	the	baseline	non‐vortexed	and	vortexed	
samples	were	15.7	and	67.4	nmol/L,	respectively.
3.1 | Storage effect
For non‐vortex mixed samples, the mean concentration of 25‐
OH	VitD	on	day	0	was	 not	 found	 to	 differ	 significantly	 on	day	1,	
(P	 =	 .654).	 However,	 on	 day	 2,	 the	 level	 was	 significantly	 higher	
(P	<	.001)	by	8.50%.	This	was	followed	by	fluctuations	in	the	mean	
value on subsequent days, with a slight decrease in the mean on day 
3, then a slight increase on day 5, but in all cases, the mean remained 
significantly	higher	compared	with	the	mean	at	day	0	(Table	2).	An	
ANOVA	 for	 the	 results	 of	 the	 non–vortex‐mixed	 specimens	 indi‐
cated a significant time effect, Wilks’ Lambda = 0.225, F = 11.83, 
P < .05, η2 = 0.77. This indicated that there was a significant trend 
toward	a	rise	in	mean	concentration	of	25‐OH	VitD	compared	with	
day	0	(fresh	specimens)	over	time	(Figure	1).
TA B L E  2  Mean	concentration	of	25‐OH	VitD	in	analyzed	samples	at	different	time	intervals
Day
Non‐vortexed Vortexed
P* 
Mean ± SD 
(nmol/L)
Subsequent days to day 0
Mean ± SD 
(nmol/L)
Subsequent days to day 0
Diff.
P
Diff.
PBias % Bias %
0 34.12 ± 12.97    33.66 ± 12.97    .118
1 34.26 ± 13.72 0.14 0.41 .654 35.10 ± 13.19 0.75 4.28 .043 .003
2 37.02 ± 13.20 2.90 8.50 .000 35.85 ± 13.01 1.50 6.51 .087 .171
3 35.18 ± 13.29 1.06 3.11 .039 35.47 ± 13.04 1.12 5.38 .039 .473
4 35.73 ± 12.89 1.61 4.72 .000 36.65 ± 13.35 2.30 8.88 .000 .037
5 36.54 ± 13.97 2.42 7.09 .000 34.98 ± 13.17 0.63 3.92 .118 .002
15 36.99 ± 13.22 2.87 8.41 .000 36.55 ± 13.75 2.20 8.59 .004 .499
30 35.99 ± 12.63 1.87 5.48 .000 34.05 ± 12.71 0.58 1.16 .118 .025
Note: Diff.	refers	to	the	mean	difference	in	serum	25‐OH	VitD	results	on	subsequent	days	compared	with	day	0	with	the	P value of the correspond‐
ing day.
*P refers to the difference in results between non‐vortexed and vortexed specimens. 
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Similarly, there was a clear difference in the measured concen‐
trations	 of	 mean	 serum	 25‐OH	 VitD	 throughout	 all	 storage	 days	
for the vortex‐mixed serum specimens compared with day 0 mean 
(Figure	1).	There	were	also	significant	differences	(P	<	.05)	in	mean	
values	 on	 day	 1,	 3,	 4,	 and	 15	 compared	with	 day	 0	 (Table	 2).	 An	
ANOVA	of	vortex‐mixed	specimens	showed	a	significant	difference	
in the mean values measured at different times, Wilks’ Lambda = 0.48, 
F = 3.76, P < .05, η2 = 0.52.	Although	this	indicates	that	there	was	a	
significant trend toward a rise in mean concentration of serum 25‐
OH	VitD	compared	with	day	0	(fresh	specimens)	over	time	but	this	
trend was not as apparent as found in the non‐vortexed samples 
(Figure	1).
3.2 | Mixing (vortexing) effect
Comparing mean levels between non‐vortexed and vortexed speci‐
mens that were measured on the same day, there were significant 
differences (P	<	.05)	between	them	on	days	1,	4,	5,	and	30,	but	not	
on days 0, 2, 3, and 15 (P	>	.05;	Table	2).
4  | DISCUSSION
The	 literature	 provides	 useful	 information	 regarding	 25‐OH	 VitD	
pre‐analytical stability using different analytical methods and 
experimenting with different storage conditions.5‐7 Previous studies 
suggest	 that	 serum	25‐OH	VitD	 is	 a	 stable	 analyte	 under	 various	
conditions,	with	no	significant	change	in	25‐OH	VitD	concentration	
was	observed	under	multiple	freeze‐thaw	cycles,	light	exposure,	or	
different storage conditions.
On the other hand, having the advantage of a larger popula‐
tion	sample	size,	our	study	showed	that	 there	was	a	statistically	
significant	difference	in	serum	25‐OH	VitD	levels	when	measured	
with or without sample vortexing over different time intervals, up 
to	30	days	in	samples	stored	at	−20°C.	We	assume	that	these	sta‐
tistical differences may be associated with sample homogeneity 
in the vortexed serum samples compared with the non‐vortexed 
samples and sample evaporation for the day‐by‐day analysis due 
to storage.
The reason for the statistical significant differences in our out‐
comes compared with previous studies 5‐7	is	unclear.	However,	they	
may result from the larger population sample of our study, and the 
differences in their local protocols, that is, short time intervals while 
our protocol has been extended up to 30 days of storage.
Data on the biological variability of analyte concentrations have 
important implications in clinical chemistry, including assessment 
of the significance of differences between consecutive results ob‐
tained in a single patient.9 The most widely accepted approach for 
this	 purpose	 is	 use	of	 the	 so‐called	 reference	 change	 value	 (RCV)	
described	by	Harris	and	Brown	in	1979.10
F I G U R E  1  Visual	summary	of	changes	in	mean	concentrations	±	SE	of	25‐OH	VitD	with	and	without	vortex	in	each	day	of	analysis
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Brescia's study suggests that individual biological variability 
and	analytical	variability	may	affect	the	variability	of	25‐OH	VitD	
analysis.11	 They	used	 the	DiaSorin	 LIAISON	chemiluminescence	
immunoassay, which is the same principle to our assay using 
Architect	 i2000,	 to	assess	 single	 individual,	 intra‐individual	bio‐
logical	variability,	and	analytical	variability	of	25‐OH	VitD.11 They 
assessed	 the	 variation	 in	 serial	 measurements	 of	 25‐OH	 VitD	
samples, and they concluded that the reference change value 
(RCV)	was	18.0%.11
Thus, differences in values not exceeding the RCV have no 
clinical significance on patient outcomes. Our results showed that 
differences on each subsequent days, for non‐vortexed and vor‐
texed specimens, did not exceed the maximum value of 8.88%. 
While most of the differences obtained in our study were statisti‐
cally significant, but at the same time, they were not considered as 
clinically significant as it did not exceed the recommended RCV for 
25‐OH	VitD	of	18%.11
The	allowable	total	error	(TEa)	is	another	quality	parameter.	It	
refers to the amount of error that is allowable without invalidat‐
ing the interpretation of a test result or reaching the clinical de‐
cision thresholds. It can be expressed as the maximum allowable 
bias and imprecision which can be calculated for each analyte. The 
TEa	 for	25‐OH	Vit	D	 is	46%.	 It	means	 that	 the	value	with	a	bias	
of more than 46% from the original value will be significant. This 
value	was	calculated	by	the	Advisory	Panel	of	Vitamin	D	External	
Quality	Assessment	Scheme	 (DEQAS),12 and it was based on the 
most common proficiency testing programs. In our study, the max‐
imum difference between intervals, mixing, and without mixing 
measurements	was	 8.88%.	 This	 value	was	 less	 than	 the	 TEa	 for	
25‐OH	Vit	D.
Therefore, our data show that it is unnecessary to vortex speci‐
mens	before	the	measurement	of	25‐OH	VitD.	This	is	a	useful	prac‐
tical observation because time to finish the batches of high number 
of samples in the clinical laboratory can be decreased by omitting 
the vortex step. Productivity in the clinical laboratory will increase 
as	well.	The	data	showed	that,	when	measuring	serum	25‐OH	VitD,	
carrying out analysis can be on the day of collection or the following 
days	as	changes	 in	25‐OH	VitD	did	not	exceed	 the	 recommended	
mentioned	 RCV	 and	 TEa.	 Even	 with	 normal	 storage	 condition	 of	
−20°C,	serum	25‐OH	VitD	concentration	is	stable	in	all	samples	ana‐
lyzed	during	the	following	days.	This	feature	of	stability	is	important	
for	 the	purpose	of	25‐OH	VitD	batching	analysis	 in	both	research	
studies and diagnostic settings.
In addition to this, our outcomes show that there is no need for 
<−20°C	storage	condition	(eg,	<−75°C	freezer)	to	keep	intact	samples	
integrity	for	testing	25‐OH	VitD	for	up	to	1	month	period.
This study had the limitation that the RCV was obtained using 
the	 LIAISON,	 Diasorin	 analyzer,	 alone.	 Therefore,	 it	 is	 suggested	
in	the	future	to	obtain	the	RCV	on	Abbott,	Architect	i2000	as	this	
was	not	provided	in	previous	literatures.	Another	limitation	that	the	
study was designed to include healthy subjects only but those with 
other	pathological	conditions	with	extreme	25‐OH	VitD	values	were	
not considered.
5  | CONCLUSION
In conclusion, delayed analysis and running samples without vortex‐
ing	have	no	“clinically	significant”	effect	on	25‐OH	VitD	level.	Such	
outcomes can save time and efforts which are important factors in 
both diagnostic and research laboratories.
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